

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.70475544 |
| 2 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.61382640 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.47092216 |
| 4 | proline biosynthetic process (GO:0006561) | 3.43843780 |
| 5 | regulation of early endosome to late endosome transport (GO:2000641) | 3.40461643 |
| 6 | barbed-end actin filament capping (GO:0051016) | 3.40311798 |
| 7 | protein localization to endosome (GO:0036010) | 3.39686586 |
| 8 | COPI coating of Golgi vesicle (GO:0048205) | 3.36725972 |
| 9 | Golgi transport vesicle coating (GO:0048200) | 3.36725972 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.34424386 |
| 11 | regulation of extracellular matrix disassembly (GO:0010715) | 3.34322738 |
| 12 | NADH metabolic process (GO:0006734) | 3.32426265 |
| 13 | mannose metabolic process (GO:0006013) | 3.29268618 |
| 14 | pinocytosis (GO:0006907) | 3.29234940 |
| 15 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.23234218 |
| 16 | angiotensin maturation (GO:0002003) | 3.17350300 |
| 17 | urea cycle (GO:0000050) | 3.13780404 |
| 18 | apoptotic process involved in morphogenesis (GO:0060561) | 3.09574357 |
| 19 | regulation of cholesterol homeostasis (GO:2000188) | 3.07254299 |
| 20 | glycosphingolipid catabolic process (GO:0046479) | 3.04812757 |
| 21 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.01931348 |
| 22 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.97820349 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 2.96590716 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 2.96590716 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.96590716 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.96590716 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.96590716 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 2.96590716 |
| 29 | protein retention in ER lumen (GO:0006621) | 2.95695276 |
| 30 | glucose 6-phosphate metabolic process (GO:0051156) | 2.94670826 |
| 31 | urea metabolic process (GO:0019627) | 2.94540859 |
| 32 | regulation of superoxide anion generation (GO:0032928) | 2.87265762 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.87243450 |
| 34 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.86147415 |
| 35 | protein-lipid complex assembly (GO:0065005) | 2.84824066 |
| 36 | plasma lipoprotein particle assembly (GO:0034377) | 2.84567321 |
| 37 | proline metabolic process (GO:0006560) | 2.83946117 |
| 38 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.83553478 |
| 39 | basement membrane organization (GO:0071711) | 2.82745732 |
| 40 | detection of bacterium (GO:0016045) | 2.81816783 |
| 41 | peptide catabolic process (GO:0043171) | 2.79923279 |
| 42 | adhesion of symbiont to host (GO:0044406) | 2.79690390 |
| 43 | glycolipid catabolic process (GO:0019377) | 2.79649662 |
| 44 | detection of other organism (GO:0098543) | 2.78316872 |
| 45 | positive regulation of extracellular matrix organization (GO:1903055) | 2.72376787 |
| 46 | response to peptidoglycan (GO:0032494) | 2.67754660 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 2.67603573 |
| 48 | negative regulation of cell killing (GO:0031342) | 2.67046726 |
| 49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.67046726 |
| 50 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.64023941 |
| 51 | modulation by symbiont of host cellular process (GO:0044068) | 2.62867051 |
| 52 | GDP-mannose metabolic process (GO:0019673) | 2.61697587 |
| 53 | regulation of extracellular matrix organization (GO:1903053) | 2.61491519 |
| 54 | stress fiber assembly (GO:0043149) | 2.61302159 |
| 55 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.61090226 |
| 56 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.61090226 |
| 57 | activation of Rac GTPase activity (GO:0032863) | 2.60119565 |
| 58 | response to laminar fluid shear stress (GO:0034616) | 2.59928198 |
| 59 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.59583275 |
| 60 | fructose metabolic process (GO:0006000) | 2.58556454 |
| 61 | negative regulation of viral release from host cell (GO:1902187) | 2.58544388 |
| 62 | pentose-phosphate shunt (GO:0006098) | 2.57184093 |
| 63 | adhesion of symbiont to host cell (GO:0044650) | 2.56503076 |
| 64 | virion attachment to host cell (GO:0019062) | 2.56503076 |
| 65 | negative regulation of fatty acid transport (GO:2000192) | 2.54698214 |
| 66 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.54661592 |
| 67 | protein carboxylation (GO:0018214) | 2.53645546 |
| 68 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.53645546 |
| 69 | NIK/NF-kappaB signaling (GO:0038061) | 2.53626705 |
| 70 | maternal placenta development (GO:0001893) | 2.49985477 |
| 71 | focal adhesion assembly (GO:0048041) | 2.45324809 |
| 72 | cell-substrate adherens junction assembly (GO:0007045) | 2.45324809 |
| 73 | oligosaccharide catabolic process (GO:0009313) | 2.45248263 |
| 74 | embryonic process involved in female pregnancy (GO:0060136) | 2.44354921 |
| 75 | diacylglycerol metabolic process (GO:0046339) | 2.43419866 |
| 76 | regulation of cholesterol esterification (GO:0010872) | 2.42699306 |
| 77 | modulation by virus of host process (GO:0019054) | 2.42515660 |
| 78 | positive regulation of receptor recycling (GO:0001921) | 2.41797384 |
| 79 | glucose catabolic process (GO:0006007) | 2.40527907 |
| 80 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.40275936 |
| 81 | low-density lipoprotein particle clearance (GO:0034383) | 2.38975664 |
| 82 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.38903124 |
| 83 | adherens junction assembly (GO:0034333) | 2.36951956 |
| 84 | amyloid precursor protein catabolic process (GO:0042987) | 2.35251274 |
| 85 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.34824187 |
| 86 | phospholipid efflux (GO:0033700) | 2.33624871 |
| 87 | detection of external biotic stimulus (GO:0098581) | 2.33151413 |
| 88 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.31452526 |
| 89 | negative regulation of cell size (GO:0045792) | 2.31158801 |
| 90 | cell-substrate junction assembly (GO:0007044) | 2.30923042 |
| 91 | epithelial cell-cell adhesion (GO:0090136) | 2.30840140 |
| 92 | regulation of cholesterol metabolic process (GO:0090181) | 2.30602092 |
| 93 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.29890146 |
| 94 | regulation of necrotic cell death (GO:0010939) | 2.29268992 |
| 95 | regulation of leukocyte degranulation (GO:0043300) | 2.28688625 |
| 96 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.27718743 |
| 97 | hyaluronan catabolic process (GO:0030214) | 2.26614982 |
| 98 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.26011864 |
| 99 | negative regulation of fibrinolysis (GO:0051918) | 2.25260811 |
| 100 | peptidyl-proline hydroxylation (GO:0019511) | 2.24193824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.10829266 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.81723643 |
| 3 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.81391136 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.72906268 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52764201 |
| 6 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.47830953 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.45952134 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.44732376 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.40630809 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.35489158 |
| 11 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.21442189 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.20686577 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.14898407 |
| 14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.13574560 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07071548 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.95315388 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.94547075 |
| 18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.89987474 |
| 19 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.80063055 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74642055 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.66294332 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65728412 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.61851075 |
| 24 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55961980 |
| 25 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55830987 |
| 26 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.53486118 |
| 27 | KDM2B_26808549_Chip-Seq_K562_Human | 1.51611662 |
| 28 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.49106189 |
| 29 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47867895 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.46271163 |
| 31 | P68_20966046_ChIP-Seq_HELA_Human | 1.45410100 |
| 32 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.44373192 |
| 33 | * MAF_26560356_Chip-Seq_TH1_Human | 1.44357969 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42846706 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41446167 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.40479703 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39028974 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38548216 |
| 39 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38355312 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38081504 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38029783 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36513866 |
| 43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34480668 |
| 44 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.34282270 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34225662 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33448918 |
| 47 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30790724 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30730499 |
| 49 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30537821 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28550500 |
| 51 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28537695 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27095649 |
| 53 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27042348 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26769446 |
| 55 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.26188780 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25695829 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25684965 |
| 58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25662470 |
| 59 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.24567396 |
| 60 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.24467784 |
| 61 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.24372306 |
| 62 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23688062 |
| 63 | * MAF_26560356_Chip-Seq_TH2_Human | 1.23568538 |
| 64 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22587369 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21054018 |
| 66 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20700823 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.20692051 |
| 68 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.19236301 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19172711 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18100480 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17058992 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16906723 |
| 73 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16865519 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15890526 |
| 75 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.13015898 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13002293 |
| 77 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12983339 |
| 78 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12599839 |
| 79 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.12194452 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11601477 |
| 81 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10774158 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.09347806 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08901468 |
| 84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07863492 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07762438 |
| 86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06946816 |
| 87 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06700176 |
| 88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02567740 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01872254 |
| 90 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99337784 |
| 91 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.98932147 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98235528 |
| 93 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97551106 |
| 94 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.96998656 |
| 95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96357269 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95735386 |
| 97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94659378 |
| 98 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.94312712 |
| 99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94179124 |
| 100 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93327535 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.50305514 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.46203934 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.46202049 |
| 4 | MP0005360_urolithiasis | 3.38125131 |
| 5 | MP0009840_abnormal_foam_cell | 3.19212264 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.48936338 |
| 7 | MP0008260_abnormal_autophagy | 2.44373094 |
| 8 | MP0003303_peritoneal_inflammation | 2.39423856 |
| 9 | MP0003436_decreased_susceptibility_to | 2.36891435 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.35431689 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.26022704 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.20995806 |
| 13 | MP0004858_abnormal_nervous_system | 2.15430058 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.11427287 |
| 15 | MP0003566_abnormal_cell_adhesion | 1.88284945 |
| 16 | MP0003300_gastrointestinal_ulcer | 1.87030035 |
| 17 | MP0001849_ear_inflammation | 1.75075386 |
| 18 | MP0005409_darkened_coat_color | 1.74880313 |
| 19 | MP0004185_abnormal_adipocyte_glucose | 1.69004900 |
| 20 | MP0000858_altered_metastatic_potential | 1.67467959 |
| 21 | MP0000678_abnormal_parathyroid_gland | 1.64552077 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 1.63949455 |
| 23 | MP0005076_abnormal_cell_differentiation | 1.63054424 |
| 24 | MP0003453_abnormal_keratinocyte_physiol | 1.60156924 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.54275468 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.53184560 |
| 27 | MP0002796_impaired_skin_barrier | 1.50251757 |
| 28 | MP0002877_abnormal_melanocyte_morpholog | 1.48824811 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.44580892 |
| 30 | MP0000685_abnormal_immune_system | 1.44195531 |
| 31 | MP0005365_abnormal_bile_salt | 1.42890498 |
| 32 | MP0000490_abnormal_crypts_of | 1.41755833 |
| 33 | MP0004947_skin_inflammation | 1.38057580 |
| 34 | MP0002419_abnormal_innate_immunity | 1.37207904 |
| 35 | MP0005025_abnormal_response_to | 1.35849349 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.29827156 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.28374966 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.24817547 |
| 39 | MP0005023_abnormal_wound_healing | 1.23992029 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.23180166 |
| 41 | MP0003091_abnormal_cell_migration | 1.22941439 |
| 42 | MP0005387_immune_system_phenotype | 1.21284041 |
| 43 | MP0001790_abnormal_immune_system | 1.21284041 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.21058845 |
| 45 | MP0005501_abnormal_skin_physiology | 1.16887018 |
| 46 | MP0002089_abnormal_postnatal_growth/wei | 1.15203988 |
| 47 | MP0001835_abnormal_antigen_presentation | 1.14978783 |
| 48 | MP0009379_abnormal_foot_pigmentation | 1.14269290 |
| 49 | MP0004272_abnormal_basement_membrane | 1.13649945 |
| 50 | MP0005085_abnormal_gallbladder_physiolo | 1.13336688 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.12738336 |
| 52 | MP0003075_altered_response_to | 1.11595440 |
| 53 | MP0009278_abnormal_bone_marrow | 1.06968000 |
| 54 | MP0003279_aneurysm | 1.06317798 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.04964219 |
| 56 | MP0003724_increased_susceptibility_to | 1.01677000 |
| 57 | MP0003329_amyloid_beta_deposits | 0.99995576 |
| 58 | MP0005375_adipose_tissue_phenotype | 0.98976613 |
| 59 | MP0006082_CNS_inflammation | 0.98818054 |
| 60 | MP0005000_abnormal_immune_tolerance | 0.98711084 |
| 61 | MP0000604_amyloidosis | 0.98710955 |
| 62 | MP0003828_pulmonary_edema | 0.97811334 |
| 63 | MP0000609_abnormal_liver_physiology | 0.97379280 |
| 64 | MP0004510_myositis | 0.97020914 |
| 65 | MP0009785_altered_susceptibility_to | 0.96662453 |
| 66 | MP0005166_decreased_susceptibility_to | 0.94396866 |
| 67 | MP0002132_abnormal_respiratory_system | 0.92785466 |
| 68 | MP0001958_emphysema | 0.92442406 |
| 69 | MP0008469_abnormal_protein_level | 0.91608974 |
| 70 | MP0001845_abnormal_inflammatory_respons | 0.91415601 |
| 71 | MP0004019_abnormal_vitamin_homeostasis | 0.86961633 |
| 72 | MP0003866_abnormal_defecation | 0.86268015 |
| 73 | MP0004233_abnormal_muscle_weight | 0.85371728 |
| 74 | MP0000343_altered_response_to | 0.84518514 |
| 75 | MP0002723_abnormal_immune_serum | 0.84432656 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.84028082 |
| 77 | MP0001819_abnormal_immune_cell | 0.83962046 |
| 78 | MP0002420_abnormal_adaptive_immunity | 0.83677417 |
| 79 | MP0000477_abnormal_intestine_morphology | 0.83634405 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 0.83430167 |
| 81 | MP0002452_abnormal_antigen_presenting | 0.83335525 |
| 82 | MP0000767_abnormal_smooth_muscle | 0.80828993 |
| 83 | MP0010329_abnormal_lipoprotein_level | 0.80765082 |
| 84 | MP0002060_abnormal_skin_morphology | 0.80607667 |
| 85 | MP0001873_stomach_inflammation | 0.79907755 |
| 86 | MP0001800_abnormal_humoral_immune | 0.78599389 |
| 87 | MP0002396_abnormal_hematopoietic_system | 0.77564133 |
| 88 | MP0000003_abnormal_adipose_tissue | 0.75944515 |
| 89 | MP0000681_abnormal_thyroid_gland | 0.74692988 |
| 90 | MP0009931_abnormal_skin_appearance | 0.74671110 |
| 91 | MP0009643_abnormal_urine_homeostasis | 0.74490633 |
| 92 | MP0003448_altered_tumor_morphology | 0.73237387 |
| 93 | MP0003763_abnormal_thymus_physiology | 0.73203149 |
| 94 | MP0001663_abnormal_digestive_system | 0.73086284 |
| 95 | MP0003123_paternal_imprinting | 0.72783389 |
| 96 | MP0000747_muscle_weakness | 0.72367218 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.71658466 |
| 98 | MP0001915_intracranial_hemorrhage | 0.71201955 |
| 99 | MP0000249_abnormal_blood_vessel | 0.71197509 |
| 100 | MP0005165_increased_susceptibility_to | 0.70750518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 3.31150590 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.21143025 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 3.16205800 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.08850340 |
| 5 | Premature rupture of membranes (HP:0001788) | 3.01998907 |
| 6 | Vertebral compression fractures (HP:0002953) | 2.93197927 |
| 7 | Hemorrhage of the eye (HP:0011885) | 2.91019584 |
| 8 | Abnormality of macrophages (HP:0004311) | 2.70394421 |
| 9 | Malnutrition (HP:0004395) | 2.69568117 |
| 10 | Achilles tendon contracture (HP:0001771) | 2.65128661 |
| 11 | Abnormality of the Achilles tendon (HP:0005109) | 2.60037866 |
| 12 | Abnormality of complement system (HP:0005339) | 2.56155768 |
| 13 | Thin bony cortex (HP:0002753) | 2.53500854 |
| 14 | Flat acetabular roof (HP:0003180) | 2.49798973 |
| 15 | Cellulitis (HP:0100658) | 2.42055865 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.40257427 |
| 17 | Purpura (HP:0000979) | 2.39661164 |
| 18 | Increased connective tissue (HP:0009025) | 2.39213525 |
| 19 | Xanthomatosis (HP:0000991) | 2.38731106 |
| 20 | Dysostosis multiplex (HP:0000943) | 2.37815841 |
| 21 | Cerebral aneurysm (HP:0004944) | 2.31315528 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 2.31003495 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.31003495 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.31003495 |
| 25 | Distal lower limb muscle weakness (HP:0009053) | 2.30816405 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.29656870 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.25924031 |
| 28 | Distal lower limb amyotrophy (HP:0008944) | 2.22508615 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16523246 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 2.14720622 |
| 31 | Axonal loss (HP:0003447) | 2.14244099 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.13597825 |
| 33 | Gingivitis (HP:0000230) | 2.12055404 |
| 34 | Cervical subluxation (HP:0003308) | 2.11889015 |
| 35 | Polycythemia (HP:0001901) | 2.10858520 |
| 36 | Myopathic facies (HP:0002058) | 2.09924169 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.09505095 |
| 38 | Complement deficiency (HP:0004431) | 2.07673835 |
| 39 | Disproportionate tall stature (HP:0001519) | 2.06782305 |
| 40 | Mucopolysacchariduria (HP:0008155) | 2.06493479 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06493479 |
| 42 | Abnormal gallbladder physiology (HP:0012438) | 2.05183886 |
| 43 | Cholecystitis (HP:0001082) | 2.05183886 |
| 44 | Distal upper limb amyotrophy (HP:0007149) | 2.04006521 |
| 45 | Upper limb amyotrophy (HP:0009129) | 2.04006521 |
| 46 | Obstructive lung disease (HP:0006536) | 2.03776160 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03776160 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01882668 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01882668 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01882668 |
| 51 | Amyloidosis (HP:0011034) | 1.99083311 |
| 52 | Abnormality of carpal bone ossification (HP:0006257) | 1.98322078 |
| 53 | Glomerulonephritis (HP:0000099) | 1.93753312 |
| 54 | Colitis (HP:0002583) | 1.93523612 |
| 55 | Hyperparathyroidism (HP:0000843) | 1.93317691 |
| 56 | Ulnar bowing (HP:0003031) | 1.93202934 |
| 57 | Loss of speech (HP:0002371) | 1.92761468 |
| 58 | Blue sclerae (HP:0000592) | 1.92294865 |
| 59 | Stridor (HP:0010307) | 1.92104589 |
| 60 | Emphysema (HP:0002097) | 1.91653328 |
| 61 | Bulbar palsy (HP:0001283) | 1.91072933 |
| 62 | Bone pain (HP:0002653) | 1.90866674 |
| 63 | Increased variability in muscle fiber diameter (HP:0003557) | 1.90465102 |
| 64 | Abnormality of the thoracic spine (HP:0100711) | 1.89150104 |
| 65 | Hyperacusis (HP:0010780) | 1.88840842 |
| 66 | Polygenic inheritance (HP:0010982) | 1.88361775 |
| 67 | Fragile skin (HP:0001030) | 1.88254439 |
| 68 | Hypertriglyceridemia (HP:0002155) | 1.87014401 |
| 69 | Abnormal ossification of hand bones (HP:0005921) | 1.86382803 |
| 70 | Ileus (HP:0002595) | 1.85482287 |
| 71 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84914807 |
| 72 | Hypertensive crisis (HP:0100735) | 1.84084975 |
| 73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83109356 |
| 74 | Myocardial infarction (HP:0001658) | 1.81036953 |
| 75 | Aneurysm (HP:0002617) | 1.80723287 |
| 76 | Pathologic fracture (HP:0002756) | 1.80643542 |
| 77 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.78020930 |
| 78 | Vacuolated lymphocytes (HP:0001922) | 1.77216217 |
| 79 | Gastrointestinal dysmotility (HP:0002579) | 1.76721830 |
| 80 | Gastrointestinal stroma tumor (HP:0100723) | 1.75956021 |
| 81 | Abdominal distention (HP:0003270) | 1.75230586 |
| 82 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75069344 |
| 83 | Gastrointestinal inflammation (HP:0004386) | 1.74350831 |
| 84 | Increased IgE level (HP:0003212) | 1.74021978 |
| 85 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.72085571 |
| 86 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.71361866 |
| 87 | Elevated alkaline phosphatase (HP:0003155) | 1.70722225 |
| 88 | Gastrointestinal infarctions (HP:0005244) | 1.69960913 |
| 89 | Hypophosphatemia (HP:0002148) | 1.68726063 |
| 90 | Thoracic kyphosis (HP:0002942) | 1.68623698 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 1.67777293 |
| 92 | Increased serum ferritin (HP:0003281) | 1.67593659 |
| 93 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.66571834 |
| 94 | Upper motor neuron abnormality (HP:0002127) | 1.65704984 |
| 95 | Petechiae (HP:0000967) | 1.64407509 |
| 96 | Joint hemorrhage (HP:0005261) | 1.64065939 |
| 97 | Easy fatigability (HP:0003388) | 1.63409417 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 1.63267434 |
| 99 | Mediastinal lymphadenopathy (HP:0100721) | 1.61935485 |
| 100 | Hydroxyprolinuria (HP:0003080) | 1.61718475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.57128335 |
| 2 | ERN1 | 4.25630458 |
| 3 | SMG1 | 3.18510016 |
| 4 | PRPF4B | 3.06988904 |
| 5 | SIK1 | 2.72222598 |
| 6 | IRAK3 | 2.70946282 |
| 7 | ICK | 2.41134930 |
| 8 | MAP2K3 | 2.26428921 |
| 9 | EPHA2 | 2.21372036 |
| 10 | RIPK1 | 2.12036342 |
| 11 | FGFR4 | 2.02200847 |
| 12 | EEF2K | 1.91346834 |
| 13 | NME2 | 1.86264629 |
| 14 | MAP3K3 | 1.80525552 |
| 15 | MAP3K11 | 1.65330421 |
| 16 | RIPK4 | 1.63681475 |
| 17 | PKN2 | 1.59038092 |
| 18 | MAP3K10 | 1.58578262 |
| 19 | TAOK2 | 1.57036910 |
| 20 | MST1R | 1.55615432 |
| 21 | MAP4K1 | 1.52075209 |
| 22 | TTN | 1.49631760 |
| 23 | TESK2 | 1.43812187 |
| 24 | IRAK4 | 1.42542266 |
| 25 | TESK1 | 1.41435003 |
| 26 | TAOK1 | 1.39473901 |
| 27 | TYK2 | 1.36758829 |
| 28 | KSR2 | 1.36745380 |
| 29 | MAP3K1 | 1.33756276 |
| 30 | MAP3K13 | 1.33058652 |
| 31 | CDK12 | 1.32184156 |
| 32 | PTK6 | 1.30418670 |
| 33 | EPHB1 | 1.28835988 |
| 34 | PAK4 | 1.24389850 |
| 35 | ARAF | 1.19847504 |
| 36 | PRKD2 | 1.18427302 |
| 37 | PDPK1 | 1.15241837 |
| 38 | TBK1 | 1.14865416 |
| 39 | PDGFRA | 1.04326617 |
| 40 | CDC42BPA | 1.00935909 |
| 41 | PRKG2 | 0.96784857 |
| 42 | ZAP70 | 0.95962640 |
| 43 | CSK | 0.93439226 |
| 44 | MAP3K8 | 0.93122804 |
| 45 | BLK | 0.92123635 |
| 46 | PTK2 | 0.91395205 |
| 47 | GRK6 | 0.88817042 |
| 48 | LMTK2 | 0.86845979 |
| 49 | MAP3K2 | 0.86003245 |
| 50 | LRRK2 | 0.85630758 |
| 51 | BMX | 0.85134238 |
| 52 | DDR2 | 0.85043983 |
| 53 | MARK2 | 0.82345942 |
| 54 | MAPK11 | 0.78237800 |
| 55 | MTOR | 0.74125700 |
| 56 | IRAK2 | 0.72551523 |
| 57 | MAP3K6 | 0.70553925 |
| 58 | BRAF | 0.70296830 |
| 59 | PDK1 | 0.68992114 |
| 60 | RPS6KA2 | 0.66601754 |
| 61 | JAK3 | 0.64124394 |
| 62 | EPHB2 | 0.62673610 |
| 63 | RPS6KC1 | 0.61948075 |
| 64 | RPS6KL1 | 0.61948075 |
| 65 | PRKD3 | 0.61853355 |
| 66 | CDK4 | 0.60151041 |
| 67 | TGFBR2 | 0.60055232 |
| 68 | PIM2 | 0.59678400 |
| 69 | TNK2 | 0.59197662 |
| 70 | MAP2K2 | 0.57234701 |
| 71 | MAP3K14 | 0.56979709 |
| 72 | DYRK1B | 0.56084294 |
| 73 | MOS | 0.53377959 |
| 74 | RET | 0.52450486 |
| 75 | FGFR3 | 0.51390879 |
| 76 | BTK | 0.49994773 |
| 77 | CDK7 | 0.49755042 |
| 78 | ABL2 | 0.49002769 |
| 79 | MAPK12 | 0.47966840 |
| 80 | STK10 | 0.47362297 |
| 81 | HIPK2 | 0.45513122 |
| 82 | ILK | 0.44241527 |
| 83 | CSF1R | 0.44018287 |
| 84 | MAPKAPK2 | 0.43931253 |
| 85 | HCK | 0.43300231 |
| 86 | FGR | 0.43268129 |
| 87 | DMPK | 0.39887239 |
| 88 | STK38 | 0.39327319 |
| 89 | RPS6KA6 | 0.38357627 |
| 90 | MET | 0.37390843 |
| 91 | MATK | 0.36305231 |
| 92 | MAP3K7 | 0.35210660 |
| 93 | KDR | 0.34238863 |
| 94 | LATS2 | 0.33917448 |
| 95 | SIK2 | 0.33120302 |
| 96 | TYRO3 | 0.31519375 |
| 97 | MAP2K6 | 0.29796677 |
| 98 | PAK1 | 0.29723427 |
| 99 | FES | 0.28405987 |
| 100 | SIK3 | 0.27734355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.37090040 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.97431511 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.92709556 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.18552629 |
| 5 | Galactose metabolism_Homo sapiens_hsa00052 | 2.10811587 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.06049726 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.94531742 |
| 8 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.76870532 |
| 9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.62385465 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60263090 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.51016282 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.49738668 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47451525 |
| 14 | Bladder cancer_Homo sapiens_hsa05219 | 1.45817735 |
| 15 | Prion diseases_Homo sapiens_hsa05020 | 1.45161069 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42216237 |
| 17 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.42040368 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39977026 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.33645558 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31311474 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.30959972 |
| 22 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.30673526 |
| 23 | Sulfur relay system_Homo sapiens_hsa04122 | 1.29637540 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.27996524 |
| 25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25945076 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.25106285 |
| 27 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.22705567 |
| 28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16232002 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15213087 |
| 30 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12836221 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12662566 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12495021 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07007319 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06513331 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.03604929 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02094035 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.00406635 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00103414 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94233301 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94228538 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 0.91010992 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90278685 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88911539 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 0.88493069 |
| 45 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88019708 |
| 46 | Insulin resistance_Homo sapiens_hsa04931 | 0.87593425 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87166763 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86571315 |
| 49 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84053252 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.84045197 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 0.83210810 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82773469 |
| 53 | Thyroid cancer_Homo sapiens_hsa05216 | 0.82210199 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.81450400 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81181876 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78447196 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78100056 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.77986389 |
| 59 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75969670 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75821761 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74787936 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.74224778 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.73927361 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73342107 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.73165404 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.71944205 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71483905 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70053356 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.69722521 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69191954 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.68527844 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68357578 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.65608180 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.65422240 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63288702 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62327365 |
| 77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61161595 |
| 78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60080692 |
| 79 | Malaria_Homo sapiens_hsa05144 | 0.59804823 |
| 80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59784591 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59450904 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59154841 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57883072 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57846067 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57367549 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57040296 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56337099 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56263498 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53785101 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53002126 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.52756348 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51570493 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51395448 |
| 94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49869495 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.49614949 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.47860427 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46940140 |
| 98 | Measles_Homo sapiens_hsa05162 | 0.46889246 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46784474 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46618378 |

